Skip to main content

Scientists complete the first successful transplant of lab-grown lungs

Image used with permission by copyright holder

For the first time ever, lungs grown in a lab have been successfully transplanted into pigs, allowing them to breathe normally with no medical complications. The breakthrough achievement opens up the possibility of using similarly bioengineered lungs for humans in need of a lung transplant.

“This is the first time someone has transplanted a whole bioengineered organ,” Joan Nichols, associate director of the Galveston National Laboratory at University of Texas Medical Branch, told Digital Trends. “We also demonstrate amazing tissue growth and development of the vascular system. There was no infection, no rejection of tissues, and animals tolerated the bioengineered lung transplant very well.”

Recommended Videos

To make the lab-grown lungs, the researchers first created a scaffold which came from an unrelated donor pig. They achieved this using a process in which all cells and blood are removed from the organ, leaving just a skeleton. Next, the researchers removed a single lung from a pig as the cell source to produce a bioengineered tissue-matched lung for transfer. This was treated with growth factor-filled hydrogels and nanoparticles to prepare the scaffold for the addition of cells, which came from a single lung taken from each of the “patient” pigs 30 days before the operation. The finished bioengineered lung — featuring cells from the patient — was then transplanted into the pigs.

Please enable Javascript to view this content

Six bioengineered lungs were created in total, although only four animals were capable of receiving them due to surgical issues.

“The lungs continued to grow and develop in each animal’s body,” Nichols said. “The growth factors help the cells to survive, and also help us make sure that when we add each type of cell — vascular or blood vessel or lung-specific cell — onto the scaffold that the cells stay where we need them to be.”

Previous work by the team has shown that it is possible to produce a pediatric-sized lung which could be used in human patients. To get to the point of clinical trials, Nichols estimated an additional five to eight years of preclinical testing is needed. Once this is complete, however, the results could be a game-changer in terms of ending organ transplant waiting lists.

A paper describing the work was recently published in the journal Science Translational Medicine.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Hyundai Ioniq 5 sets world record for greatest altitude change
hyundai ioniq 5 world record altitude change mk02 detail kv

When the Guinness World Records (GWR) book was launched in 1955, the idea was to compile facts and figures that could finally settle often endless arguments in the U.K.’s many pubs.

It quickly evolved into a yearly compilation of world records, big and small, including last year's largest grilled cheese sandwich in the world.

Read more
Global EV sales expected to rise 30% in 2025, S&P Global says
ev sales up 30 percent 2025 byd sealion 7 1stbanner l

While trade wars, tariffs, and wavering subsidies are very much in the cards for the auto industry in 2025, global sales of electric vehicles (EVs) are still expected to rise substantially next year, according to S&P Global Mobility.

"2025 is shaping up to be ultra-challenging for the auto industry, as key regional demand factors limit demand potential and the new U.S. administration adds fresh uncertainty from day one," says Colin Couchman, executive director of global light vehicle forecasting for S&P Global Mobility.

Read more
Faraday Future could unveil lowest-priced EV yet at CES 2025
Faraday Future FF 91

Given existing tariffs and what’s in store from the Trump administration, you’d be forgiven for thinking the global race toward lower electric vehicle (EV) prices will not reach U.S. shores in 2025.

After all, Chinese manufacturers, who sell the least expensive EVs globally, have shelved plans to enter the U.S. market after 100% tariffs were imposed on China-made EVs in September.

Read more